Sp-cAMPS is a cAMP analog that acts as a potent activator of cAMP-dependent protein kinases PKAI and PKAII; it is also a competitive inhibitor of phosphodiesterase PDE3A (Ki = 47.6 µM) and binds to the PDE10 GAF domain with an EC50 of 40 µM. In hepatocytes, Sp-cAMPS mimics glucagon-induced responses, including increases in intracellular Ca2+ levels. In vivo, direct infusion of Sp-cAMPS (1 µg/µL) into the prefrontal cortex significantly improves working memory performance in withdrawn mice and impairs it in water-control animals following chronic alcohol consumption.